04 January 2026 – Big Pharma doubles down on AI discovery + the prompt that cleans up messy SOPs

January 04, 2026 · Read time: under 4 minutes

AIxBiotech – weekly brief

Reporting from Zug, Switzerland — Europe’s biotech hub

Presented by OUR SPONSOR

Traveling with Swiss or Lufthansa group?

With the Uptrip app you collect cards per flight which you can exchange for lounge access, points, miles, and even Frequent Flyer status. Referral code: AL-8B866938-E147. Sign up for free via this link, use referral code: AL-8B866938-E147 and start with 4 cards.

Try the free app now


This week’s Biotech meets AI

3 headlines to be aware of

3 Biotech Breakthroughs

1️⃣ 🧬 Pfizer expands its AI discovery engine with a multi-year platform upgrade.
The pharma giant is scaling internal models across chemistry, biology, and clinical data—moving AI from pilot teams into core R&D infrastructure.
🔗 Read more at STAT News

2️⃣ 🧠 Isomorphic Labs reports progress on AI-designed oncology candidates.
DeepMind’s drug arm shared new validation data showing improved hit rates and reduced design cycles—reinforcing confidence in AlphaFold-driven pipelines.
🔗 Read more at Nature Biotechnology

3️⃣ 🧪 Insilico Medicine publishes Phase II design for its AI-origin fibrosis drug.
The study outlines how AI-guided chemistry shortened preclinical timelines—a key test case for regulators watching algorithm-led discovery.
🔗 Read more at BioPharma Dive

Also find our Crunchbase.com listing here as of today: https://www.crunchbase.com/organization/aixbiotech


From the Biotech Frontier

Zug skyline with biotech and AI network overlay

Sanofi strengthened its early pipeline by signing a multi-target AI discovery deal with a European AI biotech, combining proprietary patient data with generative models.

Roche expanded its AI diagnostics strategy by acquiring a minority stake in a pathology-AI company focused on digital biomarkers and trial stratification.

➤ A U.S. autonomous lab operator secured Series B funding to scale closed-loop AI-driven experimentation, compressing months of wet-lab work into days.

AIxBiotech


AI Academy: The SOP rewriter prompt

When you face a complex lab protocol or SOP draft, ask your AI assistant:

“Rewrite this procedure for clarity and consistency. Use numbered steps, specify reagent concentrations and timing, flag ambiguous phrases, and add Q&A annotations for training.”

💡 It turns messy procedures into clean, auditable docs your QA team will actually thank you for.

⚙️ AI Tools: Work smarter, not harder

1️⃣ 🧠 Notion AI — Turns scattered notes, tables, and project docs into structured summaries and action lists for R&D and ops teams.
🔗 notion.so

2️⃣ ⚙️ Glean — Enterprise search powered by AI, letting teams instantly find answers across SOPs, slide decks, and internal docs.
🔗 glean.com

3️⃣ 📬 Superhuman for Teams — AI summaries and follow-ups for long email threads, ideal for partner, regulatory, and BD conversations.
🔗 superhuman.com

Quick pulse check

Your feedback makes this newsletter better.

Partner with AIxBiotech

Reach biotech operators and leaders across Europe and the US. Sponsor a section or run a product spotlight.

Contact us